Emily Jordison
Obstetrics & Gynecology · Ames, IANPI 1780965400
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,003 of the $1,288 with a category attached, or 77.9%. 19 manufacturers reported payments, led by Astellas Pharma US Inc at 32.1% of the total.
Across 55 payments — averaging $23.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$414
- Biogen$163
- AbbVie$142
- Exeltis, USA Inc.$86
- Idorsia Pharmaceuticals US Inc$84
- Organon$55
- plus $345 from 13 others
What the payments were for
- Food & beverage$1,00378%
- Education$28522%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 9 | $414 |
| Biogen | 7 | $163 |
| AbbVie | 7 | $142 |
| Exeltis, USA Inc. | 5 | $86 |
| Idorsia Pharmaceuticals US Inc | 5 | $84 |
| Organon | 3 | $55 |
| Coopersurgical, Inc. | 3 | $53 |
| Agile Therapeutics, Inc. | 3 | $41 |
| Pfizer | 2 | $40 |
| Hologic Sales And Service, LLC | 2 | $34 |
| Medtronic | 1 | $28 |
| Octapharma USA, Inc. | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Mayne Pharma Commercial LLC | 1 | $17 |
| Myovant Sciences Inc. | 1 | $17 |
| Bayer | 1 | $16 |
| Merck | 1 | $15 |
| AstraZeneca | 1 | $13 |
How this compares
$1,288 in reported general payments places this provider in the 75th percentile of 274 obstetrics & gynecology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Junel FeNorethindrone-E.Estradiol-Iron | 11 | $30 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Ames
- Joyce LinesAmes$4K
- Emily ZoulekAmes$3K
- Mary RottoAmes$2K
- Jorge SotolongoCouncil Bluffs$171K
- Laura NealDubuque$157K
- Amy BingamanDes Moines$44K
- Alvadore OsbornWest Des Moines$34K
- Jason RexrothCedar Rapids$16K
- Maxwell MageeWest Des Moines$16K
- Lori PlattCouncil Bluffs$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.